The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2010Validation of Enzymatic Activity and Neuropathology in G2019S LRRK2-induced Dopaminergic Neurodegeneration in a Pre-clinical Model of Parkinson's Disease
Objective/Rationale:
Mutations in the LRRK2 gene are a common cause of familial and sporadic Parkinson’s disease. Familial LRRK2 mutations induce neuronal toxicity in vitro. Reliable pre-clinical... -
MJFF Research Grant, 2010Generation and Characterization of iPS Neurons from PINK1- and Parkin-linked Parkinson's Disease
Objective/Rationale:
Recent reports have demonstrated that skin cells from patients with Parkinson’s disease can be reprogrammed into pluripotent stem cells (iPS) and subsequently differentiated into... -
MJFF Research Grant, 2010Generation and Characterization of iPS Neurons from PINK1- and Parkin-linked Parkinson's Disease
Objective/Rationale:
Recent reports have demonstrated that skin cells from patients with Parkinson’s disease can be reprogrammed into pluripotent stem cells (iPS) and subsequently differentiated into... -
MJFF Research Grant, 2010Support for your Collaboration on Proof-of-concept clinical trial on the use of the 5-HT1A/1B Partial Agonist Eltoprazine for Treatment of L-DOPA-induced Dyskinesias. - Linked to Bjorklund CIA 2009
Objective/Rationale:
We have identified a new potential drug target for Parkinson's disease -- receptors located on the so-called serotonin neurons in the brain -- for alleviation of involuntary... -
Rapid Response Innovation Awards, 2010MicroRNAs as Biomarkers for Parkinson's Disease; A Comparison of CSF and Blood
Objective/Rationale:
We, and many other groups, hypothesize that miRNAs have the potential to be selective and sensitive diagnostic indicators for Parkinson’s disease. The focus of this project is to... -
Rapid Response Innovation Awards, 2010The Role of Alpha-synuclein in the Pathogenesis of Parkinson's Disease in a Pre-clinical Model
Objective/Rationale:
We hypothesized that alpha-synuclein increased level and accumulation within the target neurons in the affected model acts as a trigger mechanism for activation of additional...
![Two female doctors talking in the lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/apply-for-grant-404-Large-Image-Callout-A-1.jpg?h=2a1ad497&itok=G0wNEbIM)
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.